Get comprehensive genetic testing for Gastrointestinal Stromal Tumors (GIST) with our Cancer Targeted Gene Panel. Priced at $676 USD
BRAF Mutation Analysis Test in USA for $200 USD. Advanced molecular diagnostics for cancer detection. Available in New York BRAF Mutation Analysis Test Original price was: $300.Current price is: $200.
Get comprehensive CEBPA Mutation Detection testing for leukemia diagnosis and treatment planning. Available across USA including New York CEBPA Mutation Detection Test Original price was: $376.Current price is: $250.
Sale!

Cancer Targeted Gene Panel Gastrointestinal Stromal Tumor (GIST) Test

Original price was: $876.Current price is: $676.

-23%

The Cancer Targeted Gene Panel for Gastrointestinal Stromal Tumor (GIST) is a comprehensive genetic analysis that identifies specific mutations driving tumor growth. This advanced molecular test examines key genes including KIT, PDGFRA, BRAF, TP53, CD117, DOG-1, and ERBB2 to provide crucial information for targeted therapy selection. Priced at $676 USD, this test helps oncologists develop personalized treatment strategies by identifying the specific genetic alterations responsible for GIST development. The results enable precision medicine approaches, potentially improving treatment outcomes and reducing unnecessary side effects from ineffective therapies.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

Cancer Targeted Gene Panel Gastrointestinal Stromal Tumor (GIST) Test

Comprehensive Genetic Analysis for Precision Cancer Treatment

The Cancer Targeted Gene Panel for Gastrointestinal Stromal Tumor (GIST) represents a breakthrough in molecular diagnostics for cancer management. This sophisticated genetic test provides comprehensive analysis of key mutations that drive the development and progression of gastrointestinal stromal tumors, enabling oncologists to create highly personalized treatment plans based on your tumor’s specific genetic profile.

What This Advanced Test Measures and Detects

Our comprehensive GIST gene panel analyzes multiple critical genetic markers that play essential roles in tumor development and treatment response:

  • KIT and PDGFRA Mutations: The primary drivers in approximately 85% of GIST cases
  • BRAF Mutations: Important for identifying alternative treatment pathways
  • TP53 Alterations: Tumor suppressor gene mutations affecting prognosis
  • CD117 (c-KIT) Expression: Key diagnostic marker for GIST identification
  • DOG-1 Detection: Highly specific marker for GIST diagnosis
  • ERBB2 Analysis: Additional therapeutic target assessment

Who Should Consider This Genetic Test

This comprehensive genetic panel is recommended for individuals experiencing:

  • Newly diagnosed gastrointestinal stromal tumors
  • Recurrent or metastatic GIST requiring treatment optimization
  • Resistance to current tyrosine kinase inhibitor therapies
  • Unexplained abdominal pain, gastrointestinal bleeding, or early satiety
  • Family history of GIST or related genetic syndromes
  • Need for precise treatment selection before starting targeted therapy

Significant Benefits of Genetic Testing for GIST

Undergoing comprehensive genetic analysis provides numerous advantages for your cancer treatment journey:

  • Personalized Treatment Selection: Identify the most effective targeted therapies based on your specific mutation profile
  • Improved Treatment Outcomes: Higher response rates with properly matched medications
  • Reduced Side Effects: Avoid ineffective treatments and unnecessary toxicity
  • Prognostic Information: Better understand your cancer’s behavior and progression risk
  • Clinical Trial Eligibility: Access to novel treatments based on genetic markers
  • Family Risk Assessment: Identify potential hereditary components

Understanding Your Test Results

Your comprehensive genetic report will provide detailed information about:

  • Mutation Status: Specific genetic alterations identified in your tumor
  • Therapeutic Implications: Recommended targeted therapies based on mutations
  • Prognostic Significance: How genetic findings impact treatment expectations
  • Clinical Actionability: Clear guidance for next treatment steps
  • Interpretation Support: Expert analysis to help you understand complex genetic data

Our genetic counselors and oncology specialists will help interpret your results and discuss their implications for your treatment plan.

Test Pricing and Availability

Test Name Regular Price Discount Price
Cancer Targeted Gene Panel Gastrointestinal Stromal Tumor (GIST) Test $876 USD $676 USD

Nationwide Testing Availability

We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our network of certified laboratories ensures consistent, high-quality testing standards nationwide.

Take Control of Your Cancer Treatment Today

Don’t leave your treatment to chance. Comprehensive genetic testing provides the roadmap to more effective, personalized cancer care. Our expert team is ready to guide you through the testing process and help you understand how genetic insights can transform your treatment approach.

Call or WhatsApp us today at +1(267) 388-9828 to schedule your Cancer Targeted Gene Panel GIST Test and take the first step toward precision cancer medicine.

Turnaround Time: Sample due Tuesday by 9 AM | Report available in 10 working days
Sample Type: Formalin fixed paraffin embedded tissue block
Testing Methods: Immunohistochemistry and Next-Generation Sequencing (NGS)
Specialty: Oncology | Department: Molecular Diagnostics

SKU: 472 Category:

Related products